The TFDA conducts GMP inspections for medical devices by evaluating the manufacturer’s facilities, reviewing production processes, and assessing quality management systems. Inspectors examine documentation, equipment maintenance, staff training, and adherence to safety standards. They may perform on-site visits, audits, and follow-up inspections... Read More
Taiwan GMP (TGMP) certification for medical devices is a quality assurance system that ensures manufacturers comply with Good Manufacturing Practice standards. It covers all aspects of production, including design, manufacturing, quality control, and risk management. TGMP certification is mandatory for medical device... Read More
Manufacturing requirements for medical devices in Taiwan include compliance with Taiwan GMP (TGMP) standards, which mandate a quality management system, proper documentation, and risk management processes. Manufacturers must ensure product traceability, conduct regular testing and audits, maintain staff training, and adhere to... Read More
The TFDA handles non-clinical data for medical device approvals by reviewing documentation related to preclinical studies, including biocompatibility, physical and chemical properties, and performance testing. This data helps assess the device’s safety and effectiveness prior to human use. The TFDA requires comprehensive... Read More
Clinical data requirements for Class III medical devices in Taiwan include comprehensive evidence demonstrating safety, efficacy, and performance. Manufacturers must provide results from extensive clinical trials, risk assessments, and post-market surveillance plans. The data must comply with applicable regulations and guidelines, ensuring... Read More
Clinical data requirements for Class II medical devices in Taiwan include providing evidence of safety and efficacy through clinical evaluation reports. Manufacturers must submit data from relevant studies that demonstrate the device’s performance under intended conditions of use. This data must comply... Read More
The TFDA evaluates the safety of medical devices by reviewing submitted clinical data, risk assessments, and manufacturing processes. This includes assessing the results of preclinical and clinical trials, examining the device’s design and materials, and ensuring compliance with relevant standards. The TFDA... Read More
The MFDS approves clinical trial data for medical devices by thoroughly reviewing submitted data to assess safety, efficacy, and compliance with regulatory standards. This includes evaluating trial design, methodologies, and participant outcomes. The MFDS may request additional information or conduct site inspections... Read More
GCP requirements for medical device clinical trials include obtaining ethical approval, ensuring informed consent from participants, and adhering to trial protocols. Investigators must maintain accurate and complete records, conduct trials according to established guidelines, and ensure participant safety. Additionally, adverse events must... Read More
Clinical trials in South Korea are regulated by the MFDS through comprehensive guidelines that ensure compliance with Good Clinical Practice (GCP) standards. The MFDS reviews and approves clinical trial applications, monitors trial conduct, and inspects sites for adherence to protocols. It also... Read More